Table 4 Multivariate analysis of 611 cases (18 were left out due to missing values) treated at least 24 hours, odds ratio for death or other unfavourable (transfer out, default, physician's decision to stop early) outcomes. Reference category is favourable treatment outcome

Sex

female

34

1

28

1

male

68

2.51 (1.42–4.45)

0.002

48

1.47 (0.83–2.61)

0.18

Age at diagnosis

risk per five years

102

1.29 (1.16–1.42)

<0.001

76

0.96 (0.88–1.041)

0.29

Immunosuppression

no

74

1

72

1

yes

28

2.11 (1.12–3.97)

0.020

4

0.32 (0.097–1.062)

0.063

TB history

no

96

1

73

1

yes

6

0.36 (0.133–0.97)

0.044

3

0.32 (0.087–1.16)

0.082

Specialty responsible for ending treatment

pulmonary

58

1

67

1

internal medicine

16

14.08 (4.76–41.66)

<0.001

4

6.89 (1.66–28.59)

0.008

general medicine

22

6.24 (3.00–12.98)

<0.001

4

2.11 (0.65–6.86)

0.21

other

6

4.72 (1.46–15.33)

0.010

1

0.58 (0.060–5.68)

0.64

Pause of treatment

no

86

1

36

1

yes

16

0.69 (0.33–1.47)

0.34

40

3.46 (1.92–6.27)

<0.001

Treatment group

standard treatment A

60

1

23

1

standard treatment B

7

0.85 (0.30–2.42)

0.76

19

5.92 (2.61–13.44)

<0.001

standard treatment C

1

0.146 (0.017–1.22)

0.076

6

1.41 (0.48–4.12)

0.53

standard treatment D

24

1.42 (0.76–2.67)

0.28

15

0.94 (0.45–1.95)

0.86

other combination

8

1.15 (0.43–3.07)

0.79

11

1.54 (0.63–3.75)

0.34

ineffective

2

2.64 (0.29–24.38)

0.39

2

3.54 (0.49–25.30)

0.21